Latest profit margin for Pharmicell , Ltd.: 31.3% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
Pharmicell , Ltd.'s profit margin stands at 31.3% as of September 2026. That compares with 28.51% in the prior-year period — up 9.8% year over year. That is above the Healthcare sector average of 17.63%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Pharmicell , Ltd. reported 31.3% in profit margin versus 28.51% a year earlier — a 9.8% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
Pharmicell , Ltd. sits higher the Healthcare benchmark (17.63%) with a profit margin of 31.3%. That is roughly 77.5% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A profit margin of 31.3% for Pharmicell , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Pharmicell , Ltd.'s profit margin evolved across reporting periods, while the comparison chart places 005690.KS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.